4-phenylbutylamine has been researched along with Reperfusion Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chao, CT; Chen, JH; Chiang, CK; Huang, JW; Hung, KY; Liu, SH; Tarng, DC | 1 |
Jin, M; Li, L; Luo, L; Tong, J; Wang, Y; Zhu, Y | 1 |
2 other study(ies) available for 4-phenylbutylamine and Reperfusion Injury
Article | Year |
---|---|
Early elimination of uremic toxin ameliorates AKI-to-CKD transition.
Topics: Acute Kidney Injury; Animals; Butylamines; Carbon; Drug Evaluation, Preclinical; Indican; Mice, Inbred C57BL; Nephrosclerosis; Oxides; Renal Insufficiency, Chronic; Reperfusion Injury; Senescence-Associated Secretory Phenotype; Unfolded Protein Response | 2021 |
Xenon postconditioning attenuates neuronal injury after spinal cord ischemia/reperfusion injury by targeting endoplasmic reticulum stress-associated apoptosis.
Topics: Animals; Apoptosis; Endoplasmic Reticulum Stress; Humans; Rats; Reperfusion Injury; Spinal Cord Ischemia | 2023 |